PureTech's latest spinoff Celea Therapeutics was created to progress the former's lead respiratory IPF programme, ...

Insmed’s drug Brinsupri (brensocatib) has landed a double regulatory landmark win, becoming both the first marketed dipeptidyl peptidase 1 (DPP1) inhibitor and the first therapy for non-cystic ...

The government has announced feed-in tariffs, its revised Power Development Plan 8 (PDP 8) and other policies.